TABLE I.
Total patients, no. | 388 |
Age, mean (range), yr | 59 (20–88) |
Sex, no. (%) | |
Male | 303 (78) |
Female | 85 (22) |
Location of primary tumor, no. (%) | |
Oropharynx | 144 (37) |
Oral cavity | 85 (22) |
Larynx | 73 (19) |
Hypopharynx | 24 (6) |
Nasopharynx | 17 (4) |
Unknown | 15 (4) |
Paranasal sinus | 12 (3) |
Major salivary gland | 8 (2) |
Skin of head and neck | 6 (2) |
Other | 4 (1) |
Nasal cavity | 3 |
Lacrimal gland | 1 |
T stage, no. (%) | |
Tis | 2 (0.5) |
T1 | 47 (12) |
T2 | 127 (33) |
T3 | 77 (20) |
T4 | 103 (27) |
Tx | 32 (8) |
N stage, no. (%) | |
N0 | 127 (33) |
N1 | 73 (19) |
N2 | 150 (39) |
N3 | 21 (5) |
Nx | 17 (4) |
AJCC stage of primary tumor, no. (%) | |
0 | 2 (0.5) |
I | 9 (2) |
II | 42 (11) |
III | 78 (20) |
IV | 236 (61) |
Unknown | 21 (5) |
Early stage (I and II) | 53 (14) |
Late stage (III and IV) | 314 (81) |
Unknown | 21 (5) |
AJCC = American Joint Committee on Cancer.